VANCOUVER, B.C., March 20, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Wednesday, March 27, 2013 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to provide a corporate update and report year-end 2012 financial results. Conference Call and Webcast Information A live webcast of the call can be accessed through the Investor section of Tekmira's website at www.tekmirapharm.com. Or, alternatively, to access the conference call, please dial 914-495-8556 or 1-866-393-1607. An archived webcast will be available on the Tekmira website approximately two hours after the event. Alternatively, to access a replay of the conference call, please dial 404-537-3406 or 1-855-859-2056 and reference conference ID 26000337. About Tekmira Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
CONTACT: Investors Jodi Regts Director, Investor Relations Phone: 604-419-3234 Email: firstname.lastname@example.org Media David Ryan Longview Communications Inc. Phone: 416-649-8007 Email: email@example.com